Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905851 · ClinicalTrials.gov registry record · NA
Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02905851: Completed NA study, sponsored by University of California, Davis.
NCT02905851 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905851, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris
Primary Outcome
The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback
Interventions
- OTHER Feedback group
- OTHER Non Feedback group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02905851 record still lists
NCT02905851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Feedback group is the first listed.
NCT02905851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02905851 about?
NCT02905851 is a clinical study titled "Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris". To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris
What is the current status of trial NCT02905851?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-05. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02905851?
The interventions under investigation include: Feedback group (OTHER), Non Feedback group (OTHER).
Who is sponsoring clinical trial NCT02905851?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02905851's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia